Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada

Simple item page
dc.contributor.authorHeppner, Jonathan
dc.contributor.authorNguyen, Leonard T
dc.contributor.authorGuo, Maggie
dc.contributor.authorNaugler, Christopher
dc.contributor.authorRashid-Kolvear, Fariborz
dc.date.accessioned2019-05-26T00:20:21Z
dc.date.available2019-05-26T00:20:21Z
dc.date.issued2019-05-24
dc.date.updated2019-05-26T00:20:21Z
dc.description.abstractAbstract Objective The incidence of the combined myeloproliferative neoplasms (MPNs) was determined for a major Canadian city. Retrospective cases of MPN diagnoses (essential thrombocythemia, polycythemia vera, and primary myelofibrosis) between 2011 to 2015 were retrieved from the Southern Alberta Cancer Cytogenetics Laboratory’s database at Alberta Public Laboratories. Results An incidence rate of 2.05 cases per 100,000 person-years (95% CI 1.73–2.41) was determined, giving an age-standardized Canadian incidence of 2.71 cases per 100,000 person years (95% CI 2.63–2.78). MPN diagnoses occurred at a wide age range of 8–93 (median 66) and an age-dependent increase in incidence. Incidence rates for the MPNs are first reported here for a Canadian population.
dc.identifier.citationBMC Research Notes. 2019 May 24;12(1):286
dc.identifier.doihttps://doi.org/10.1186/s13104-019-4321-1
dc.identifier.urihttp://hdl.handle.net/1880/110428
dc.identifier.urihttps://doi.org/10.11575/PRISM/45773
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleIncidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
13104_2019_Article_4321.pdf
Size:
723.54 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications